In support of this, BAALC controls cell proliferation in AML (15, 16) and triple negative breast cancer (14) and when BAALC overexpression is combined with the self-renewal promoting oncogene HoxA9, leukemogenesis is induced in vivo (17). This evidence concerns the gene BAALC and acute myeloid leukemia.